Welcome! 👋

My Directory Profile <svg class="shrink-0 [:where(&)]:size-6 inline-block size-4 mb-1 ms-0.5" data-flux-icon xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" fill="currentColor" aria-hidden="true" data-slot="icon"> <path fill-rule="evenodd" d="M12 1.5a5.25 5.25 0 0 0-5.25 5.25v3a3 3 0 0 0-3 3v6.75a3 3 0 0 0 3 3h10.5a3 3 0 0 0 3-3v-6.75a3 3 0 0 0-3-3v-3c0-2.9-2.35-5.25-5.25-5.25Zm3.75 8.25v-3a3.75 3.75 0 1 0-7.5 0v3h7.5Z" clip-rule="evenodd"/> </svg> <span class="sr-only">(Locked)</span>

My Certificates <svg class="shrink-0 [:where(&)]:size-6 inline-block size-4 mb-1 ms-0.5" data-flux-icon xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" fill="currentColor" aria-hidden="true" data-slot="icon"> <path fill-rule="evenodd" d="M12 1.5a5.25 5.25 0 0 0-5.25 5.25v3a3 3 0 0 0-3 3v6.75a3 3 0 0 0 3 3h10.5a3 3 0 0 0 3-3v-6.75a3 3 0 0 0-3-3v-3c0-2.9-2.35-5.25-5.25-5.25Zm3.75 8.25v-3a3.75 3.75 0 1 0-7.5 0v3h7.5Z" clip-rule="evenodd"/> </svg> <span class="sr-only">(Locked)</span>

Plans & Pricing

Try a 5-day trial and earn 2 Free OT CEUs - no card required!

Try for Free

Or choose a plan to earn more CEUs and unlock all features!

Courses

Treatment Guides

Assessments

Blog

Therapy Directory

OT CEU Requirements

Directory Profile

Back to Therapy Directory

Olivia Biller

OTD, OTR/L

Johnson & Johnson

Raritan, New Jersey

Education & Licenses

Thomas Jefferson University-Center City Campus

👋 Olivia Biller is not currently accepting clients, but would like to connect with fellow professionals.

“ I am a clinical researcher, working with the Patient-Reported Outcomes group at Johnson & Johnson, measuring what matters for participants in clinical trials. ”

I got my doctorate in OT from Thomas Jefferson University in 2022, and shortly after I passed the NBCOT started a 2-year postdoctoral fellowship in Patient-Reported Outcomes at Johnson & Johnson (2022-2024). Now I am in a manger role on the PRO team (2024-present), focusing my research on neuropsychiatric and cardiopulmonary conditions. My team develops and implements the clinical outcome assessment (COA) strategy in clinical trials for drugs in late-stage development (phase 2 and phase 3 trials), and conducts quantitative/qualitative research outside of clinical trials to discover what matters most to people living with different health conditions as well as what they would consider a meaningful change in their disease. I'd love to connect with other OT's doing research and learn from your experiences.